Cargando…
Praziquantel for the treatment of schistosomiasis during human pregnancy
In 2014, an estimated 40 million women of reproductive age were infected with Schistosoma haematobium, S. japonicum and/or S. mansoni. In both 2003 and 2006, the World Health Organization (WHO) recommended that all schistosome-infected pregnant and breastfeeding women be offered treatment, with praz...
Autores principales: | Friedman, Jennifer F, Olveda, Remigio M, Mirochnick, Mark H, Bustinduy, Amaya L, Elliott, Alison M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Health Organization
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791873/ https://www.ncbi.nlm.nih.gov/pubmed/29403101 http://dx.doi.org/10.2471/BLT.17.198879 |
Ejemplares similares
-
Population Pharmacokinetics of Praziquantel in Pregnant and Lactating Filipino Women Infected with Schistosoma japonicum
por: Bustinduy, Amaya L., et al.
Publicado: (2020) -
Integration of prevention and control measures for female genital schistosomiasis, HIV and cervical cancer
por: Engels, Dirk, et al.
Publicado: (2020) -
A randomized double blind placebo controlled trial assessing the efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy
por: Olveda, Remigio M, et al.
Publicado: (2015) -
Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis
por: Bustinduy, Amaya L., et al.
Publicado: (2016) -
The praziquantel in preschoolers (PIP) trial: study protocol for a phase II PK/PD-driven randomised controlled trial of praziquantel in children under 4 years of age
por: Webb, Emily L., et al.
Publicado: (2021)